PAVmed Inc. APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition
PAVmed Inc. (PAVM) reported APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition of $375.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition · last filed 2025-11-12
- PAVmed Inc. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2025-09-30 was $375.00K, a 46.12% decline year-over-year.
- PAVmed Inc. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2025-06-30 was $155.00K, a 74.08% decline year-over-year.
- PAVmed Inc. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2025-03-31 was $637.00K, a 31.80% decline year-over-year.
- PAVmed Inc. apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2024-12-31 was $453.00K, a 54.20% decline year-over-year.
- PAVmed Inc. apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2024 was $2.68M, a 36.99% decline from fiscal 2023.
- PAVmed Inc. apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2023 was $4.25M, a 24.90% decline from fiscal 2022.
- PAVmed Inc. apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2022 was $5.67M, a 4.73% increase from fiscal 2021.
- PAVmed Inc. apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2021 was $5.41M, a 173.37% increase from fiscal 2020.
| Period end | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2025-09-30 | $375.00K 10-Q · filed 2025-11-12 | $530.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.17M 10-Q · filed 2025-11-12 | $1.62M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $155.00K 10-Q · filed 2025-08-14 | $792.00K 10-Q · filed 2025-08-14 | $1.25M derived: sum of 3 quarters · filed 2025-08-14 | $1.94M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | $637.00K 10-Q · filed 2025-05-15 | $1.09M derived: sum of 2 quarters · filed 2025-05-15 | $1.79M derived: sum of 3 quarters · filed 2025-11-12 | $2.38M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | $453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.15M derived: sum of 2 quarters · filed 2025-11-12 | $1.75M derived: sum of 3 quarters · filed 2025-11-12 | $2.68M 10-K · filed 2025-03-24 |
| 2024-09-30 | $696.00K 10-Q · filed 2025-11-12 | $1.29M derived: sum of 2 quarters · filed 2025-11-12 | $2.23M 10-Q · filed 2025-11-12 | $3.22M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $598.00K 10-Q · filed 2025-08-14 | $1.53M 10-Q · filed 2025-08-14 | $2.52M derived: sum of 3 quarters · filed 2025-08-14 | $3.50M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $934.00K 10-Q · filed 2025-05-15 | $1.92M derived: sum of 2 quarters · filed 2025-05-15 | $2.90M derived: sum of 3 quarters · filed 2025-05-15 | $3.99M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $989.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.97M derived: sum of 2 quarters · filed 2025-03-24 | $3.06M derived: sum of 3 quarters · filed 2025-03-24 | $4.25M 10-K · filed 2025-03-24 |
| 2023-09-30 | $978.00K 10-Q · filed 2024-11-14 | $2.07M derived: sum of 2 quarters · filed 2024-11-14 | $3.27M 10-Q · filed 2024-11-14 | $4.73M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $1.09M 10-Q · filed 2024-08-12 | $2.29M 10-Q · filed 2024-08-12 | $3.75M derived: sum of 3 quarters · filed 2024-08-12 | $5.23M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $1.20M 10-Q · filed 2024-05-13 | $2.66M derived: sum of 2 quarters · filed 2024-05-13 | $4.14M derived: sum of 3 quarters · filed 2024-05-13 | $5.59M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $2.94M derived: sum of 2 quarters · filed 2024-03-25 | $4.39M derived: sum of 3 quarters · filed 2024-03-25 | $5.67M 10-K · filed 2024-03-25 |
| 2022-09-30 | $1.48M 10-Q · filed 2023-11-13 | $2.93M derived: sum of 2 quarters · filed 2023-11-13 | $4.21M 10-Q · filed 2023-11-13 | $5.14M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.45M 10-Q · filed 2023-08-14 | $2.73M 10-Q · filed 2023-08-14 | $3.66M derived: sum of 3 quarters · filed 2023-08-14 | $4.88M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.28M 10-Q · filed 2023-05-15 | $2.21M derived: sum of 2 quarters · filed 2023-05-15 | $3.43M derived: sum of 3 quarters · filed 2023-05-15 | $6.05M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $937.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $2.15M derived: sum of 2 quarters · filed 2023-03-14 | $4.78M derived: sum of 3 quarters · filed 2023-03-14 | $5.41M 10-K · filed 2023-03-14 |
| 2021-09-30 | $1.22M 10-Q · filed 2022-11-14 | $3.84M derived: sum of 2 quarters · filed 2022-11-14 | $4.47M 10-Q · filed 2022-11-14 | $5.04M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $2.62M 10-Q · filed 2022-08-15 | $3.25M 10-Q · filed 2022-08-15 | $3.82M derived: sum of 3 quarters · filed 2022-08-15 | $4.39M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $631.00K 10-Q · filed 2022-05-16 | $1.20M derived: sum of 2 quarters · filed 2022-05-16 | $1.77M derived: sum of 3 quarters · filed 2022-05-16 | $2.28M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $570.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $1.14M derived: sum of 2 quarters · filed 2022-04-06 | $1.65M derived: sum of 3 quarters · filed 2022-04-06 | $1.98M 10-K · filed 2022-04-06 |
| 2020-09-30 | $570.00K 10-Q · filed 2021-11-22 | $1.08M derived: sum of 2 quarters · filed 2021-11-22 | $1.41M 10-Q · filed 2021-11-22 | |
| 2020-06-30 | $513.00K 10-Q · filed 2021-08-16 | $840.00K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $328.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |